Tamoxifen can counteract some pathologic features in mouse model of DMD

[News]

A new study has found that tamoxifen, a well-known breast cancer drug, can counteract some pathologic features in a mouse model of Duchenne muscular dystrophy (DMD). At present, no treatment is known to produce long-term improvement of the symptoms in boys with DMD, a debilitating muscular disorder that is characterized by progressive muscle wasting, respiratory and cardiac impairments, paralysis, and premature death.

More... (http://www.news-medical.net/news/20130116/Tamoxifen-can-counteract-some-pathologic-features-in-mouse-model-of-DMD.aspx)